Panel discussion on new technologies in lymphoma - the applications of circulating tumor DNA
Ash Alizadeh et al.
Why we need novel strategies for diffuse large B-cell lymphoma
Trial of ibrutinib with bendamustine and rituximab in CLL: results and study design
Curative strategy for smoldering multiple myeloma: GEM-CESAR
Integrating molecular variables into prognostic models for patients with MPNs